| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10010736 | Journal of the American Academy of Dermatology | 2005 | 7 Pages |
Abstract
This large prospective series of BCC managed by MMS is characterized by a high percentage of high-risk tumors. Most tumors were located in the mid-facial area and the histologic subtype was mainly infiltrating or nodulocystic. That previously recurrent tumors were larger and demonstrated a more extensive subclinical extension compared with primary tumors emphasizes the importance of initial tumor eradication with margin control.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Igal MD, Shyamala C. FACD, Dinesh FRANZCO, Shawn FACD, Robert FACD,